ascopubs.org16d
Understanding incidence and outcomes of testicular and ovarian germ cell tumors from 2000–2017 using population-based cancer registries.
Evaluation of MIR-371A-3P for clinical implementation in a CLIA-certified laboratory. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not ...
ascopubs.org16d
Evaluating the impact of a community-based prostate cancer screening program.
Evaluating social vulnerability as a key determinant of definitive treatment for Black men with clinically localized prostate cancer.
ascopubs.org14d
Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World Study
We conducted a retrospective cohort study of patients with TNBC treated between 2010 and 2019. Overall survival (OS) rates by stage were analyzed across various patient groups, including those ...
ascopubs.org7d
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3 ...
ascopubs.org6d
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3
Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...
ascopubs.org1d
ABCA1 and ABCG1 cholesterol transporters expression on metastatic renal cell carcinoma: Impact on immunotherapy outcomes (CHOMET study).
Association between abnormal IMDC laboratory criteria after surgery and cancer-specific and overall survival in non-metastatic renal cell carcinoma: Potential biomarkers for adjuvant therapy patient ...
ascopubs.org16d
Complications after transurethral resection of bladder tumor: Findings from the 2022 ACS NSQIP database.
Optimizing treatment approaches in nested bladder tumors: A multicenter retrospective study.
ascopubs.org16d
Circulating kidney injury molecule-1 (KIM-1) in association with kidney injury biomarkers and outcomes in metastatic renal cell carcinoma.
Optimizing clear cell renal cell carcinoma tumor-infiltrating lymphocytes under controlled hypoxic conditions. Association of KIM-1 with PFS and OS in metastatic RCC. Multivariable models are adjusted ...
ascopubs.org7d
Challenges in the Management of Advanced Prostate Cancer
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 Fig 1. Challenges in the management of advanced prostate cancer.
ascopubs.org16d
Beyond survival: Understanding the social dimensions of prostate cancer.
Treatment patterns and survival outcomes in metastatic castration-resistant prostate cancer in the Brazilian population: LACOG 1818. Trends in cardiovascular mortality in older adults with malignant ...
ascopubs.org16d
Correlates of immunotherapy response in metastatic clear cell renal cell carcinoma from circulating cell-free epigenomes.
Development of an ex-vivo platform to model immunotherapy in kidney cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not include a full ...
ascopubs.org27d
Spotlight on Lung Cancer Disparities in India
The India State-Level Disease Burden Initiative partners revealed significant variation in age-standardized incidence of the top 10 malignancies, including LC from 1990 to 2016. In men, the crude LC ...